Syed Haider

Syed Haider has a diverse work experience spanning over different industries. Their most recent position is as a Senior Director of Financial Planning and Analysis at Cerevel Therapeutics, a role they took on in August 2022. Prior to that, they served as the Director of Financial Planning and Analysis at the same company from September 2020 to August 2022. Before joining Cerevel Therapeutics, Syed worked at Mallinckrodt Pharmaceuticals, where they held the position of R&D Portfolio Management and Analysis from November 2018 to September 2020. Syed also has experience at Bristol-Myers Squibb, where they held various roles including Associate Director of International Treasury, Associate Finance Director of Company Transformation, and Associate Director of FP&A CoE and Commercial Operations. Syed has additionally worked as a Senior Financial Analyst at Sikorsky Aircraft and as a Senior Auditor at Ernst & Young. Overall, their work experience showcases their expertise in financial planning and analysis, as well as their ability to work effectively across different industries.

Syed Haider completed their High School education from IICS. Syed then pursued a Bachelors degree in Finance from Penn State University, graduating in 2006. In 2007, they joined the University of Virginia to pursue a Masters degree in Accounting, completing it in 2007. Later, Syed attended the University of Connecticut from 2009 to 2012, where they earned an MBA degree with a focus on Marketing/Marketing Management, General.